Publication | Closed Access

Response to salvage chemotherapy after progression on immune checkpoint inhibitors in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

MedicineImmune Checkpoint InhibitorsImmunologyPathologyImmune Checkpoint InhibitorHead And Neck CancerCancer TreatmentNeck OncologyImmunotherapyOncologyRadiation Oncology